Khyber Pakhtunkhwa Drug Registration Authority has suspended licenses of three pharmaceutical companies for making substandard medicines.
The Authority’s Board has also approved the registration of 60 new drugs. Media reports said that the board also approved the international standard procedure for registration of new drugs.
The drug companies were also asked to ensure quality packing of medicines.
